In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s DrugThe agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
'Some Hope Is Better Than Having No Hope' · The New York Times'Some Hope Is Better Than Having No Hope' · The New York Times